A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

NCT03107026 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: dasotraline 4mg
DRUG: dasotraline 6mg
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.